Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL140294 | 0.95 | — | — | |
| Acetic Acid SCHEMBL11494704 | 0.95 | CA1 (0.89) | — | |
| Acetic Acid SCHEMBL247894 | 0.90 | — | — | |
| Acetic Acid SCHEMBL363369 | 0.90 | — | — | |
| Acetic Acid SCHEMBL4084721 | 0.90 | CA1 (0.90) | — | |
| Acetic Acid SCHEMBL11580548 | 0.90 | — | — | |
| Acetic Acid SCHEMBL1179482 | 0.90 | CA1 (0.80) | — | |
| Acetic Acid SCHEMBL14660924 | 0.90 | CA1 (0.80) | — | |
| Acetic Acid SCHEMBL21859116 | 0.90 | — | — | |
| Acetic Acid SCHEMBL29677352 | 0.90 | CA1 (0.80) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116284759-B | Polypeptide gene vector and preparation method and application thereof | 深圳先进技术研究院 | 2025-02-11 | — | — | CN | claimed |
| EP-4741397-A1 | FUSED TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shenzhen Zhongge Biological Technology Co., Ltd. (CN) | 2026-05-13 | — | — | EP | disclosed |
| CN-119798395-A | Phyllostachys pubescens PedARF gene and application thereof in regulating and controlling plant lignin synthesis | 南京林业大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-103044278-B | Method for synthesizing levocarnitine by taking D-(-)-tartaric acid as raw material | UNIV SHENYANG CHEMICAL TECH | 2014-07-09 | — | — | CN | disclosed |
| CN-103044278-A | Method for synthesizing levocarnitine by taking D-(-)-tartaric acid as raw material | UNIV SHENYANG CHEMICAL TECH | 2013-04-17 | — | — | CN | disclosed |
| CN-101250208-B | L-nucleic acid derivative and processes for the synthesis thereof | MITSU CHEMICALS INC | 2012-06-20 | — | — | CN | disclosed |
| CN-102241720-A | L-nucleic acid derivative and processes for the synthesis thereof | MITSU CHEMICALS INC | 2011-11-16 | — | — | CN | disclosed |
| CN-102234104-A | Processing method of hydrogen bromide gas generated in bromination reaction | CHANGSHU JINGHUA CHEMICAL CO LTD | 2011-11-09 | — | — | CN | disclosed |
| CN-101250194-B | L-nucleic acid derivative and processes for the synthesis thereof | MITSUI CHEMICALS INC | 2011-05-04 | — | — | CN | disclosed |
| CN-101250208-A | L-nucleic acid derivative and processes for the synthesis thereof | MITSUI CHEMICALS INC (JP) | 2008-08-27 | — | — | CN | disclosed |
| CN-101250194-A | L-nucleic acid derivative and processes for the synthesis thereof | MITSUI CHEMICALS INC (JP) | 2008-08-27 | — | — | CN | disclosed |
| CN-100368422-C | L-nucleic acid derivatives and synthesis method thereof | MITSUI CHEMICALS INC (JP) | 2008-02-13 | — | — | CN | disclosed |
| CN-1478096-A | L-nucleic acid derivatives and synthesis method thereof | 三井化学株式会社 | 2004-02-25 | — | — | CN | disclosed |
| CN-1454203-A | Substituted nitrated catechols, their use in the treatment of certain central and peripheral nervous system disorders and pharmaceutical compositions containing them | PORTELA & CA SA (PT) | 2003-11-05 | — | — | CN | disclosed |
| US-20030148929-A1 | Nucleic acid carriers and pharmaceutical compositions for gene therapy | HISAMITSU PHARMACEUTICAL CO., INC. | 2003-08-07 | — | — | US | disclosed |
| CN-1390201-A | cyclic amine compounds as CCR5 antagonists | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-01-08 | — | — | CN | disclosed |
| EP-1229124-A1 | NUCLEIC ACID TRANSPORTER CONTAINING POLYPEPTIDE AND RECOMBINANT VIRUS VECTOR | HISAMITSU PHARMACEUTICAL CO. INC. (JP) | 2002-08-07 | — | — | EP | disclosed |
| EP-1132099-A1 | NUCLEIC ACID TRANSPORTERS AND MEDICINAL COMPOSITIONS FOR GENE THERAPY | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2001-09-12 | — | — | EP | disclosed |